Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Behav Res Ther ; 87: 142-154, 2016 12.
Article in English | MEDLINE | ID: mdl-27668723

ABSTRACT

Confusion between panic and asthma symptoms can result in serious self-management errors. A cognitive behavior psychophysiological therapy (CBPT) intervention was culturally adapted for Latinos consisting of CBT for panic disorder (PD), asthma education, differentiation between panic and asthma symptoms, and heart rate variability biofeedback. An RCT compared CBPT to music and relaxation therapy (MRT), which included listening to relaxing music and paced breathing at resting respiration rates. Fifty-three Latino (primarily Puerto Rican) adults with asthma and PD were randomly assigned to CBPT or MRT for 8 weekly sessions. Both groups showed improvements in PD severity, asthma control, and several other anxiety and asthma outcome measures from baseline to post-treatment and 3-month follow-up. CBPT showed an advantage over MRT for improvement in adherence to inhaled corticosteroids. Improvements in PD severity were mediated by anxiety sensitivity in CBPT and by depression in MRT, although earlier levels of these mediators did not predict subsequent improvements. Attrition was high (40%) in both groups, albeit comparable to CBT studies targeting anxiety in Latinos. Additional strategies are needed to improve retention in this high-risk population. Both CBPT and MRT may be efficacious interventions for comorbid asthma-PD, and CBPT may offer additional benefits for improving medication adherence.


Subject(s)
Asthma/epidemiology , Asthma/therapy , Cognitive Behavioral Therapy , Hispanic or Latino/psychology , Panic Disorder/epidemiology , Panic Disorder/therapy , Adult , Asthma/drug therapy , Biofeedback, Psychology/physiology , Comorbidity , Female , Heart Rate/physiology , Humans , Male , Medication Adherence , New York City/epidemiology , Patient Dropouts/statistics & numerical data , Relaxation Therapy , Treatment Outcome , Young Adult
2.
J Asthma ; 52(6): 606-13, 2015.
Article in English | MEDLINE | ID: mdl-25428771

ABSTRACT

OBJECTIVE: There exists large ethnic disparities in asthma among Latino children; Puerto Ricans (PRs) are disproportionately affected, while Mexicans have the lowest prevalence and morbidity. Disparities are poorly understood, however, acculturation and social support are suggested to influence asthma control among children. This study investigated the relationship between acculturation, social support and asthma control among PR and Mexican children and their caregivers. METHODS: Primary caregiver-child dyads (n = 267) of PR (n = 79) and Mexican (n = 188) descent were recruited from clinics at two inner-city hospitals in Bronx, NY and three clinics in Phoenix, AZ. Children were 5-12 years of age and had a confirmed asthma diagnosis. Dyads completed measures of social support, acculturation and asthma control; logistic regression was used for analysis. RESULTS: Mexican children had better asthma control than PR children (p < 0.001). PR caregivers were more acculturated than Mexican caregivers (p < 0.05); however, acculturation did not predict control. Across Latino subgroups caregivers' total level of social support predicted better asthma control among children (p < 0.05), and support received from family and friends each independently predicted better control (p < 0.05). CONCLUSIONS: Results suggest that social support reduces some of the burden associated with asthma management enabling caretakers to better control their children's asthma.


Subject(s)
Acculturation , Asthma/ethnology , Asthma/physiopathology , Hispanic or Latino/statistics & numerical data , Parents , Social Support , Child , Child, Preschool , Female , Humans , Male , Mexican Americans/statistics & numerical data , Puerto Rico/ethnology , Residence Characteristics , United States/epidemiology
3.
Ann Allergy Asthma Immunol ; 113(5): 565-70, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25216970

ABSTRACT

BACKGROUND: Several cross-sectional studies have found an association between respiratory disease and increased mood or anxiety disorders among adults. Little is known about the nature of these associations over time or the role of potential confounders in these links. OBJECTIVES: To investigate the association between respiratory disease and incident and persistent depression or anxiety disorders 10 years later and to examine potential pathways of these associations. METHODS: Data were drawn from the Midlife Development in the United States survey, a representative sample of adults in the United States ages 18 to 74 years. Participants (N = 2,101) were interviewed on a range of health domains at baseline at wave 1 (1994) and again at wave 2 (2005). RESULTS: Respiratory disease was associated with increased odds of depression and anxiety disorders cross-sectionally at both time points. Respiratory disease at wave 1 was not associated with incident depression or anxiety disorders at wave 2. Respiratory disease at wave 1 was associated with increased odds of persistent depression or anxiety disorders 10 years later among those with depression or anxiety disorders at wave 1. Associations were not explained by differences in demographic characteristics, secondhand smoke exposure, cigarette smoking, or history of exposure to childhood maltreatment. CONCLUSION: Findings shed new light on the association between respiratory disease and depression or anxiety disorders. Individuals with respiratory disease appear to have higher prevalence of concurrent depression or anxiety disorders and persistent depression or anxiety disorders compared with those without respiratory disease. However, a history of respiratory disease does not appear to confer increased risk of new onset of depression or anxiety disorders.


Subject(s)
Anxiety/epidemiology , Depressive Disorder/epidemiology , Respiratory Tract Diseases/epidemiology , Adolescent , Adult , Aged , Anxiety/etiology , Cross-Sectional Studies , Depressive Disorder/etiology , Female , Humans , Logistic Models , Male , Middle Aged , Prevalence , Prospective Studies , Respiratory Tract Diseases/psychology , Surveys and Questionnaires , United States/epidemiology , Young Adult
4.
Am J Clin Oncol ; 34(5): 529-36, 2011 Oct.
Article in English | MEDLINE | ID: mdl-20838323

ABSTRACT

During breast cancer radiotherapy, nearly all patients will experience radiodermatitis. Study objectives were as follows: (1) systematically review the literature on radiodermatitis and breast cancer; (2) summarize and describe patient-rated radiodermatitis measures; (3) determine whether consensus exists regarding subjective radiodermatitis measurement; and (4) provide recommendations for future research. PubMed and CINAHL were searched from their inception through August 2009. Study inclusion and exclusion criteria were: full abstract available, manuscript in English, focused on radiodermatitis resulting from breast cancer radiotherapy, and described a patient-rated empirical assessment of radiodermatitis. Three reviewers examined abstracts, and decisions about inclusion were reached by consensus. Twenty-two of 237 mutually identified studies met selection criteria. Using a standardized abstraction form, 3 authors independently extracted relevant information. Results indicated that (1) only 9% of the studies reviewed included a patient-rated measure; (2) generally, extant scales are very brief and focus almost exclusively on physical reactions, and (3) there is no "gold standard" measure of patient-rated radiodermatitis at this time. We conclude that significantly more research is needed to determine the best (most valid, reliable, sensitive, comprehensive) measure(s) to evaluate the experience of radiodermatitis from the patient's perspective, and that further scale development efforts are needed.


Subject(s)
Brachytherapy/adverse effects , Breast Neoplasms/complications , Breast Neoplasms/radiotherapy , Radiodermatitis/etiology , Female , Humans
5.
BMC Nephrol ; 10: 11, 2009 May 21.
Article in English | MEDLINE | ID: mdl-19460162

ABSTRACT

BACKGROUND: Previous studies have examined the spectrum of diseases identified with a kidney biopsy and the complications of the procedure. However, few studies have examined the utility of the test to clarify the diagnosis and guide treatment of pediatric patients. This retrospective, single-center chart review was performed to test the hypothesis that at least 80% of native kidney biopsies provide clinically valuable information that rationally guides diagnosis and patient management. METHODS: 200 biopsies performed between January 1, 2000 and June 30, 2008 were reviewed. A scheme composed of six categories was devised to classify the utility of each kidney biopsy. RESULTS: 196 complete case files were available for review. Twenty-four (12.2%) biopsies did not shed light on the diagnosis and were unhelpful in patient management - 21 biopsies (10.7%) were non-diagnostic and 3 (1.5%) failed to yield enough tissue for examination. The number of unhelpful biopsies did not cluster in any specific disease entity. CONCLUSION: Our findings provide guidance to nephrologists about the total risk of a kidney biopsy, including uninformative results, when seeking informed consent for the procedure. The results suggest an appropriate balance has been reached which maximizes the use of kidney biopsies while minimizing the risk of this invasive procedure (word count: 202).


Subject(s)
Biopsy, Needle/statistics & numerical data , Kidney Diseases/pathology , Kidney/pathology , Biopsy, Needle/adverse effects , Child , Female , Humans , Incidence , Male , New York/epidemiology , Reproducibility of Results , Retrospective Studies , Risk Assessment/methods , Risk Factors , Sensitivity and Specificity
6.
Clin Med Pediatr ; 3: 19-22, 2009.
Article in English | MEDLINE | ID: mdl-23818791

ABSTRACT

IgA nephropathy (IgAN) is a common glomerular disease whose etiology is unknown. Previous studies have described the clinical and laboratory features but none have specifically compared patients during different time periods. This 20 year retrospective study was performed to assess trends in the severity of IgAN from 1989-2008. We reviewed 57 patient charts that contained a confirmed biopsy diagnosis of IgAN and recorded data at the time of diagnosis and the final follow-up appointment. Clinical data included physical examination, urine, and blood tests. Patients were separated into two cohorts, Cohort 1 1989-1998 and Cohort 2 1999-2008. An increase in severity was noted in Cohort 2 based on a significantly higher Up/c and lower serum albumin level. Other prognostic indicators including GFRe, hematocrit, and glomerular injury score also demonstrated a trend towards more severe disease over the past 20 years. The patients in both Cohorts received similar treatments and had comparable renal function at the last follow-up visit. Based on our findings, we suggest that although a kidney biopsy is required to diagnose IgAN, the procedure may not be necessary in patients clinically suspected of having the disease but who have normal kidney function and minimal urine abnormalities.

SELECTION OF CITATIONS
SEARCH DETAIL
...